228 related articles for article (PubMed ID: 18523869)
1. LRRK2 mutation in familial Parkinson's disease in a Taiwanese population: clinical, PET, and functional studies.
Lin CH; Tzen KY; Yu CY; Tai CH; Farrer MJ; Wu RM
J Biomed Sci; 2008 Sep; 15(5):661-7. PubMed ID: 18523869
[TBL] [Abstract][Full Text] [Related]
2. Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease.
Pankratz N; Pauciulo MW; Elsaesser VE; Marek DK; Halter CA; Rudolph A; Shults CW; Foroud T; Nichols WC;
Mov Disord; 2006 Dec; 21(12):2257-60. PubMed ID: 17078063
[TBL] [Abstract][Full Text] [Related]
3. The LRRK2 I2012T, G2019S and I2020T mutations are not common in patients with essential tremor.
Deng H; Le W; Davidson AL; Xie W; Jankovic J
Neurosci Lett; 2006 Oct; 407(2):97-100. PubMed ID: 16939701
[TBL] [Abstract][Full Text] [Related]
4. Absence/rarity of commonly reported LRRK2 mutations in Indian Parkinson's disease patients.
Punia S; Behari M; Govindappa ST; Swaminath PV; Jayaram S; Goyal V; Muthane UB; Juyal RC; Thelma BK
Neurosci Lett; 2006 Dec; 409(2):83-8. PubMed ID: 17052850
[TBL] [Abstract][Full Text] [Related]
5. A novel LRRK2 mutation in an Austrian cohort of patients with Parkinson's disease.
Haubenberger D; Bonelli S; Hotzy C; Leitner P; Lichtner P; Samal D; Katzenschlager R; Djamshidian A; Brücke T; Steffelbauer M; Bancher C; Grossmann J; Ransmayr G; Strom TM; Meitinger T; Gasser T; Auff E; Zimprich A
Mov Disord; 2007 Aug; 22(11):1640-3. PubMed ID: 17523199
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinical features of LRRK2 mutations in patients with Parkinson's disease in southern Spain.
Gao L; Gómez-Garre P; Díaz-Corrales FJ; Carrillo F; Carballo M; Palomino A; Díaz-Martín J; Mejías R; Vime PJ; López-Barneo J; Mir P
Eur J Neurol; 2009 Aug; 16(8):957-60. PubMed ID: 19473361
[TBL] [Abstract][Full Text] [Related]
7. The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease.
Lu CS; Simons EJ; Wu-Chou YH; Fonzo AD; Chang HC; Chen RS; Weng YH; Rohé CF; Breedveld GJ; Hattori N; Gasser T; Oostra BA; Bonifati V
Parkinsonism Relat Disord; 2005 Dec; 11(8):521-2. PubMed ID: 16256409
[No Abstract] [Full Text] [Related]
8. Absence of commonly reported leucine-rich repeat kinase 2 mutations in Eastern Indian Parkinson's disease patients.
Sanyal J; Sarkar B; Ojha S; Banerjee TK; Ray BC; Rao VR
Genet Test Mol Biomarkers; 2010 Oct; 14(5):691-4. PubMed ID: 20722494
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants ofLRRK2 in Taiwanese Parkinson's disease.
Wu YR; Chang KH; Chang WT; Hsiao YC; Hsu HC; Jiang PR; Chen YC; Chao CY; Chang YC; Lee BH; Hu FJ; Chen WL; Lee-Chen GJ; Chen CM
PLoS One; 2013; 8(12):e82001. PubMed ID: 24339985
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: importance of G2019S and R1441C mutations in sporadic Parkinson's disease patients.
Floris G; Cannas A; Solla P; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Sardu C; Marrosu F; Marrosu MG
Parkinsonism Relat Disord; 2009 May; 15(4):277-80. PubMed ID: 18805725
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal.
Ferreira JJ; Guedes LC; Rosa MM; Coelho M; van Doeselaar M; Schweiger D; Di Fonzo A; Oostra BA; Sampaio C; Bonifati V
Mov Disord; 2007 Jun; 22(8):1194-201. PubMed ID: 17469194
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of LRRK2 parkinsonism.
Haugarvoll K; Wszolek ZK
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S205-8. PubMed ID: 20082991
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: a replication study in a Taiwanese cohort.
Wu-Chou YH; Chen YT; Yeh TH; Chang HC; Weng YH; Lai SC; Huang CL; Chen RS; Huang YZ; Chen CC; Hung J; Chuang WL; Lin WY; Chen CH; Lu CS
Parkinsonism Relat Disord; 2013 Feb; 19(2):251-5. PubMed ID: 23182315
[TBL] [Abstract][Full Text] [Related]
14. [Clinical molecular genetics for PARK8 (LRRK2)].
Tomiyama H; Hatano T; Hattori N
Brain Nerve; 2007 Aug; 59(8):839-50. PubMed ID: 17713120
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's disease.
Huang Y; Halliday GM; Vandebona H; Mellick GD; Mastaglia F; Stevens J; Kwok J; Garlepp M; Silburn PA; Horne MK; Kotschet K; Venn A; Rowe DB; Rubio JP; Sue CM
Mov Disord; 2007 May; 22(7):982-9. PubMed ID: 17427941
[TBL] [Abstract][Full Text] [Related]
16. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N
Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants.
Zhang L; Quadri M; Guedes LC; Coelho M; Valadas A; Mestre T; Lobo PP; Rosa MM; Simons E; Oostra BA; Ferreira JJ; Bonifati V
Parkinsonism Relat Disord; 2013 Oct; 19(10):897-900. PubMed ID: 23726462
[TBL] [Abstract][Full Text] [Related]
18. Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries.
Tomiyama H; Li Y; Funayama M; Hasegawa K; Yoshino H; Kubo S; Sato K; Hattori T; Lu CS; Inzelberg R; Djaldetti R; Melamed E; Amouri R; Gouider-Khouja N; Hentati F; Hatano Y; Wang M; Imamichi Y; Mizoguchi K; Miyajima H; Obata F; Toda T; Farrer MJ; Mizuno Y; Hattori N
Mov Disord; 2006 Aug; 21(8):1102-8. PubMed ID: 16622854
[TBL] [Abstract][Full Text] [Related]
19. Low frequency of common LRRK2 mutations in Mexican patients with Parkinson's disease.
Yescas P; López M; Monroy N; Boll MC; Rodríguez-Violante M; Rodríguez U; Ochoa A; Alonso ME
Neurosci Lett; 2010 Nov; 485(2):79-82. PubMed ID: 20727385
[TBL] [Abstract][Full Text] [Related]
20. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
